JPMorgan Chase & Co. Increases Position in Avanos Medical, Inc. (NYSE:AVNS)

JPMorgan Chase & Co. grew its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 189.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 201,634 shares of the company's stock after buying an additional 132,063 shares during the quarter. JPMorgan Chase & Co. owned 0.44% of Avanos Medical worth $3,210,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Jane Street Group LLC lifted its stake in Avanos Medical by 35.8% during the 3rd quarter. Jane Street Group LLC now owns 65,650 shares of the company's stock valued at $1,578,000 after acquiring an additional 17,306 shares during the period. Barclays PLC grew its holdings in Avanos Medical by 446.2% in the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after buying an additional 78,583 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Avanos Medical by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company's stock valued at $25,337,000 after buying an additional 16,065 shares during the period. Tributary Capital Management LLC increased its stake in Avanos Medical by 38.1% during the fourth quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock worth $14,217,000 after acquiring an additional 246,379 shares during the last quarter. Finally, Empowered Funds LLC raised its holdings in Avanos Medical by 141.3% in the 4th quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock valued at $2,449,000 after buying an additional 90,091 shares during the period. 95.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Avanos Medical Stock Down 1.4 %

Shares of NYSE AVNS traded down $0.18 during midday trading on Friday, hitting $12.35. 573,170 shares of the company's stock were exchanged, compared to its average volume of 334,637. The firm's fifty day simple moving average is $14.00 and its 200-day simple moving average is $16.78. The company has a market cap of $568.14 million, a PE ratio of 36.32 and a beta of 1.15. Avanos Medical, Inc. has a twelve month low of $11.84 and a twelve month high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The firm had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Insider Buying and Selling

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at approximately $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.64% of the stock is currently owned by corporate insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.